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Abstract 
To  assess  potential  effects  of  hyperbaric  oxygen  (HBOT)  on  artificial  bone  grafts,  β  – 
Tricalcium phosphate (β-TCP) and calcium phosphate coated bovine bone (CPCBB) substi-
tutes were applied to standard bone defects in rat tibiae. The control defects were left empty. 
Half of the animals received 60 minutes of 2.4 atmosphere absolute (ATA) of HBOT. Rats 
were sacrificed at one, two and four weeks. Bone healing was assessed histologically and 
histomorphometrically using light microscopy. The periosteum over the bone defects was 
examined ultrastructurally. Cardiac blood was collected to determine the serum osteocalcin 
levels. The HBOT increased new bone formation in the unfilled controls and β-TCP groups 
and significantly decreased cartilage matrix and fibrous tissue formations in all groups. Active 
osteoblasts and highly organized collagen fibrils were prominent in the periosteum of β-TCP 
and control groups. Serum osteocalcin levels also increased with HBOT. The healing of de-
fects filled with CPCBB was similar to the controls and it did not respond to HBOT. These 
findings suggested that the HBOT had beneficial effects on the healing of unfilled bone defects 
and those filled with β-TCP bone substitute but not with CPCBB, indicating a material-specific 
influence pattern of HBOT. 
Key words: Hyperbaric oxygen, beta tricalcium phosphate, calcium phosphate coated bovine bone, 
light microscopy, ultrastuctural, rat 
Introduction 
Autogenous bone grafts facilitate natural healing 
process  by  providing  adequate  amount  of  mineral 
structure,  collagen,  growth  factors  and  progenitor 
cells (1,2). Therefore, it is widely accepted as the "gold 
standard" of the bone grafting procedures in the oral 
and maxillofacial region. However, creation of a se-
cond surgical site, prolonged operation time, donor 
site morbidity, inadequate bone volume and chronic 
pain are also associated with clinical complications of 
autogenous bone harvesting (3). Thus, several alter-
natives  to  autogenous  bone  have  been  developed 
which  use  a  variety  of  materials,  including  natural 
and synthetic polymers, ceramics, and composites (4). 
β – Tricalcium phosphate (β-TCP) ceramics are 
bioabsorbable compounds which act as a scaffold for 
new vessel and bone formations (5). β-TCP has been 
used for alveolar bone and maxillary sinus augmen-
tation procedures as well as the repair of periodontal 
and peri-implant bone defects (6,7,8). Another com-
mon bone graft used for similar clinical purposes is Int. J. Med. Sci. 2011, 8 
 
http://www.medsci.org 
115 
the particle form of inorganic bovine bone which is 
manufactured  from  animal  bones.  It  is  ther-
mo-chemically  treated  in  order  to  extract  organic 
constituents (9). Both of these materials are potential 
alternatives  to  the  autogenous  bone  in  the  osseous 
reconstructive surgery, especially when smaller graft 
volumes are required (10). However, these materials 
also  share  similar  disadvantages.  Long-term  fol-
low-up studies has shown significant histological de-
lays in the replacement of these materials with newly 
formed bone tissue, even after six (11) and 12 months 
(12). Experimental studies also indicate lower overall 
success rate and less bone to implant contact ratio in 
dental implants placed in regions which were previ-
ously  grafted  using  aforementioned  types  of  bone 
substitutes (13). To overcome these issues, the fabri-
cation  of  tissue  engineered  biomaterials,  different 
combinations of bone grafts and systemic supportive 
therapy alternatives are important areas of research.  
Hyperbaric oxygen therapy (HBOT) is a mode of 
medical treatment in which the patient breathes 100 % 
oxygen  at  a  pressure  greater  than  one  atmosphere 
absolute (ATA) in an entirely enclosed in a pressure 
chamber  (14).  Hyperbaric  condition  increases  the 
amount of oxygen dissolved in the blood; therefore, it 
can reach areas which are impenetrable for the red 
blood cells and provide tissue oxygenation in case of 
impaired hemoglobin concentration or function (15). 
In  Oral  and  Maxillofacial  surgery,  HBOT  is  mainly 
used  to  prevent  or  to  treat  radiotherapy  associated 
osteonecrosis of the jaws (16). In addition, this treat-
ment modality has been found successful in increas-
ing the incorporation rate of autogenous bone grafts 
(17) and soft tissue flaps (18), as well as dental implant 
success rates (19) in the irradiated mandible.  
Although  HBOT  is  considered  a  valuable  ad-
junct on the healing of bone lesions in different ana-
tomical regions with ischemic perfusion, the current 
knowledge about its influence on bone graft substi-
tutes  used  in  oral  reconstructive  surgery  is  limited. 
Therefore, the aim of this study was to evaluate his-
tological  and  biochemical  effects  of  HBOT  on  the 
healing of normally perfused experimental bone de-
fects filled with β – TCP or calcium phosphate coated 
bovine bone (CPCBB) grafting materials. 
Materials and Methods 
Animals 
The experiments were carried out on adult male 
Sprague-Dawley  rats  (N=126)  weighing  approxi-
mately 250 g ± 20 g, obtained from the Istanbul Uni-
versity, Institute for Experimental Medical Research 
(DETAE). All animals were housed in metallic cages 
in a temperature (23±10) and humidity (60-80%) con-
trolled room under regular light and dark conditions. 
All procedures were reviewed and approved by the 
Institutional Animal Care and Use Committee at the 
Istanbul University, Institute for Experimental Medi-
cal  Research.  After  several  days  of  acclimatization, 
rats  were  randomly  assigned  to  six  experimental 
groups, each consisting of 21 rats. Three groups which 
will  be  breathing  room  air  during  the  experiments 
were named as Control, B-TCP and CPCBB. The rest 
of the animals who will be receiving HBOT, were as-
signed to Control + HBOT, B-TCP + HBOT, CPCBB + 
HBOT groups. The HBOT was planned to be admin-
istered for one, two or four weeks. At the end of each 
time points, seven animals from HBOT groups were 
sacrificed  along  with  an  equal  number  of  rats  in 
non-HBOT  groups.  The  left  tibiae  of  the  rats  were 
used for light microscopic evaluation and right tibiae 
were processed for electron microscopy. 
Surgical Procedures 
Rats were anesthetized using intraperitoneal in-
jection  of  5  mg  /  kg  of  Xylazin  hydrochloride 
(Rompun®, Bayer Turk Kimya San. Ltd. Sti. Istanbul, 
Turkey) and 60 mg / kg of Ketamin HCl (Ketanest ®, 
Parke Davis, Berlin, Germany). A longitudinal inci-
sion was made along the frontal aspect of both tibiae 
and  flaps  were  raised  to  expose  the  bone  tissue. 
Non-critical, four mm circular standard bone defects 
involving  cortical  and  cancellous  bone  layers  were 
created using a dental burr mounted on a dental ro-
tary instrument under constant irrigation and suction. 
The  β  –  TCP  (Cerasorb  ®,0.5-1.00  μm  particle  size, 
Curasan,  Bayern,  Germany)  and  CPCBB  (Bio-Cera 
®,0,6-1.00  μm  particle  size,  Osteogenic  Core  Tech-
nologies,  Choongnam,  Korea)  bone  graft  materials 
were placed using an amalgam carrier to ensure that 
an equal volume of each material was used for each 
rat. Same graft material was used in both legs. The 
control  defects  were  left  empty.  Bleeding  was  con-
trolled using sterile gauze pads. The periosteum and 
the skin were closed using 3.0 surgical sutures. The 
left tibiae of the rats were used for light microscopic 
evaluation and right tibiae were processed for elec-
tron microscopy. 
Hyperbaric oxygen protocol 
Half of the rats received HBOT in a cylindrical 
mono-place hyperbaric chamber. Following treatment 
steps were included in these sessions: 10 minutes of 
ventilation to fill the chamber with 100 % oxygen, five 
minutes of diving to 15 m (50 feet) in which the rats 
were exposed to 2.4 ATA pressure for 60 minutes, five 
minutes of re-surfacing and 10 minutes of air ventila-Int. J. Med. Sci. 2011, 8 
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tion. The treatment started immediately after the sur-
gical  procedures  were  completed.  The  HBOT  was 
given every day for one session at 10.00  am until the 
sacrification time points.  
Light microscopy preparation and histomor-
phometric analysis 
The  rats  were  euthanized  and  tibiae  were  ex-
cised. Samples were fixated in 10 % buffered formal-
dehyde  solution.  Soft  tissues  were  cleaned  and  the 
specimens  were  decalcified  in  formic  acid  sodium 
nitrate solution. The regions with bone defects were 
further  sectioned  and  embedded  in  paraffin. 
Mid-sagittal serial sections of 7 µm thick  were pre-
pared and stained with hematoxylin and eosin. The 
histologic  slides  were  examined  using  light  micros-
copy under different magnifications. New bone for-
mation  (NBF),  fibrous  tissue  formation  (FTF),  carti-
lage  tissue  formation  (CTF)  was  assessed  histomor-
phometrically using AnalySIS FIVE® digital imaging 
software  (Olympus  Soft  Imaging  Solutions  GmBH, 
Münster, Germany). Sections were observed at X100 
magnification and the maximum number of fields in 
each  region  that  did  not  overlap  was  included. 
Means% ± SE% of the mean for each parameter were 
determined in each region. 
Electron microscopy preparation 
The  periosteums  over  the  bone  defects  were 
carefully dissected from the surface and the tissues 
were  fixed  in  2,5  %  cacodylate  buffered  glutaralde-
hyde  solution  for  ultra-structural  examination  and 
post-fixed in 1% osmic acid for one hour. The samples 
were dehydrated through a graded series of alcohol 
and embedded in Epon 812 (Fluka AG, Buchs Swit-
zerland). The blocks were sectioned with LKB Ultra 
microtome (Stockholm, Sweden). Thick sections were 
stained with toluidin blue examined. Ultra thin sec-
tions  selected  from  appropriate  regions  were  con-
trasted with lead citrate and uranyl acetate and ex-
amined under and electron microscope (JEOL 1011, 
JEOL Ltd., Tokyo, Japan). 
Serum osteocalcin measurements 
1  ml  of  cardiac  blood  from  the  right  ventricle 
was collected immediately after the sacrification. Af-
ter  the  centrifugation,  the  serum  portion  was  sepa-
rated and processed in a rat-specific sandwich ELISA 
immunoassay  kit  (Biomedical  Technologies  Inc., 
Stoughton, U.S.A.). The amount of substrate turnover 
is determined colorimetrically by measuring the ab-
sorbance,  which  is  proportional  to  the  osteocalcin 
concentration.  
Statistical Analysis 
Graph Pad Prism® V.3 statistical analysis soft-
ware (Graph Pad Software Inc., San Diego, CA, USA) 
was used in this study. The data was first evaluated 
with descriptive statistical methods such as mean and 
standard deviation. Kruskal-Wallis test was used for 
between  group  comparison  and  Dunn’s  multiple 
comparison tests was performed for subgroups. The 
results were evaluated in a confidence interval of 95 % 
and p<0.05 was considered as statistically significant. 
 
 
Results 
Clinical Evaluation 
The animals healed uneventfully and they con-
tinued  their  routine  physiological  activities.  During 
the experiments, two rats were lost and had to be re-
placed because of the complications of general anes-
thesia. There was no animal death related to post op-
erative infections or HBOT procedures.  
Light microscopy observations  
In groups which did not receive HBOT, cartilage 
matrix formation was dominant both in control (Fig-
ure 1a) and in grafted defects. New bone formation 
was  observed  to  start  from  the  defect  margins  and 
extended through the center. At one week, small ne-
crotic  areas,  mild  inflammatory  cell  infiltration  and 
scarce new vessel formation were common findings in 
all groups. It was found that both materials initiated 
foreign  body  reactions;  however,  this  was  more 
prominent for β – TCP. There were also fibrous tissue 
gaps between the graft particles of the same material. 
At two weeks, numerous new bone trabeculae were 
observed in the fibrous connective tissue, nearly oc-
cupying the entire defects in the control group. There 
was also few scattered cartilage tissue and new vessel 
formations.  These  observations  were  also  visible 
around  the  bone  grafts  in  the  experimental  defects. 
Nevertheless, newly formed bone was more promi-
nent in the CPCBB groups than the β – TCP filled de-
fects. Mild but apparent foreign body reactions were 
still present for both graft materials. At four weeks, all 
defects in the control groups were almost filled with 
new bone tissue in spite of the grafted sites. In β – TCP 
groups,  the  residual  bone  graft  particles  were  sur-
rounded by a combination of newly formed bone and 
cartilage tissue. The new bone formation in the defects 
of  the  CPCBB  group  was  more  prominent  when 
compared to the β – TCP. 
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Figure 1 (a) Endochondral bone formation characterized by abundant cartilage matrix in the histological slide of the 
control group without HBOT at one week time point (H&E×100). (b) The histological slide of the control group which 
received HBOT at one week time point, the new bone growth and blood vessel formations (arrows) are clearly visible 
(H&E×250). (c) Histological appearance of the CPCBB group without HBOT at one week time point, note the arrows 
showing new bone trabeculae around the bone graft (H&E×40) (Cm; Cartilage matrix, Nbf; New bone formation, Gm; Graft 
material). (d) Light micrography of the β-TCP group without HBOT taken at two week time point (H&E ×100). 
 
In  groups  which  received  HBOT,  overall  bone 
healing  pattern  was  similar  to  non-HBO  groups. 
However, from a subjective point of view, new bone 
formation  was  occupying  larger  areas  which  were 
previously filled by cartilage and fibrous connective 
tissues in groups which did not receive HBOT. At one 
week, there was no prominent inflammatory cell re-
action in any of the three groups. Loose connective 
tissue and new bone trabeculae were found together 
with  small  islands  of  isolated  cartilage  tissue  and 
abundant  new  vessels  in  the  control  group  and 
around the bone grafts (Figure 1b, 1c). At two weeks, 
no cartilage or necrotic tissue formation was observed 
in the control group. Moreover, most of defects were 
already  filled  with  newly  formed  bone.  Similar  ob-
servations were made in the groups in which the bone 
grafts and HBOT were used together. There were also 
prominent new vessel formations within the connec-
tive tissue surrounding the graft particles (Figure 1d). 
At  four  weeks,  nearly  all  of  the  fibrous  tissue  was 
replaced  by  the  newly  formed  bone  in  the  control 
group. In β – TCP + HBOT group, there was some 
areas of residual graft particles surrounded mainly by 
a combination of mature and immature bone. Smaller 
areas containing graft particles were also present in 
CPCBB + HBOT group, however, the healing of de-
fects in this group were close to that of the control 
group (Figure 2, 3 and 4). 
Histomorphometry 
Fibrous  tissue  formation:  HBOT  significantly 
reduced the amount of fibrous tissue formation at one 
and two week samples of the control animals, as the 
respective  values  of  FTV  in  the  Control  group  was 
calculated to be 41,4±14,2 and 29,1±9,2 whereas same 
values for Control + HBOT group were 25±12,1 and 
14,5±4,1  (p<0.05  for  both).  Similarly,  FTV  of  the 
CPCBB + HBOT group (23,2±10,4) was significantly 
lower  than  CPCBB  group  (38,4±11,9)  at  two  weeks 
specimens (p< 0.05). 
Cartilage matrix formation: This value was sig-
nificantly lower in the control  + HBOT group (48,1 
±30,5)  when  compared  with  the  controls  (13±11,6) 
(p<0.05), at one week specimens. Also, the mean CMF 
value in the β – TCP + HBOT group (17,1±7,8) was 
significantly  lower  than  that  of  the  β  –  TCP  group 
(33±15,4) (p < 0.05) at two weeks. At the same time 
point,  these  values  were  respectively  9,8±4,8  for 
CPCBB  +  HBOT  group  and  26,4±10,6  for  CPCBB 
group (p< 0.01) and this difference indicated a statis-
tically  significant  decrease  in  the  CMF  variable  in 
between these two groups.  Int. J. Med. Sci. 2011, 8 
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New  bone  formation:  Histomorphometric 
measurements revealed that the HBOT increased new 
bone  formation  in  the  control  animals,  as  the  NBF 
value in the Control + HBOT group (58,5±17,1) was 
significantly  higher  than  that  of  the  Control  group 
(40,2±7,6)  (p<0.05)  at  two  weeks.  At  one  and  two 
weeks’ time points, there was also an increase in the 
NBF value of β – TCP + HBOT (18,7±4,7 and 45,7±11, 
respectively) when compared to the β – TCP group 
(9,2±7,7  and  20,7±7,4  respectively)  (p<0.05  and  p< 
0.01, respectively) (Table 1). 
 
 
Figure 2 New bone formation and residual graft particles were observed in the histological section taken from the β-TCP 
group with adjunctive HBOT at four week time point (H&E×200) (Nbf; New bone formation, Gm; Graft material, Ct; 
Connective tissue). 
 
 
 
Figure 3 CPCBB graft material which is gradually resorbing and resembles the necrotic bone can be seen in the middle of 
this slide. This section has been taken from the CPCBB + HBOT group which was sacrified at four week time point 
(H&E×200) (Nbf; New bone formation, Gm; Graft material, Ct; Connective tissue).  Int. J. Med. Sci. 2011, 8 
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Figure 4 The histological view of the defect which is nearly filled with newly formed bone in the control groups which had 
received four week of HBOT (H&E×200) (Nbf; New bone formation, Bm; Bone marrow). 
Table 1: Overall results of the bone histomorphometry and serum osteocalcin measurements. Data are presented as mean 
percentage value and standard deviation (FTF; fibrous tissue formation, CMF; cartilage matrix formation, NBF; new bone 
formation). 
Variables    Control Groups  ß-Tricalcium Phosphate  Calcium Phosphate Coated Bovine 
Bone 
  One 
week 
Two 
week 
Four 
week 
One 
week 
Two 
week 
Four 
week 
One week  Two week  Four week 
FTV (mean%±SD% )  HBO (-)  41,4±14,2  29,1±9,2  14,8±5,2  45,2±8,8  29,7±13,2  30,7±7,4  37,7±10,2  38,4±11,  22,5±9,0 
HBO (+)  25±12,1  14,5±4,1  13,2±10,5  35,5±13,4  32±6,0  26,8±10,1  28,7±10,8  23,2±10,4  17,2±6,9 
CMF (mean%±SD% )  HBO (-)  48,1±3,5  30,1±18,6  19,8±14,4  27±15,3  33±15,4  29,7±13,2  16,7±11,1  26,4±10,6  15,4±7,6 
HBO (+)  13±11,6  14,7±9,5  8,8±5,4  23±11,9  17,1±7,8  20±8,2  9,4±8,3  9,8±4,8  3,4±1,9 
NBF (mean%±SD% )  HBO (-)  16,2±9,9  40,2±7,6  68,1±10,1  9,29±7,7  20,7±7,4  35,4±10,5  21,2±11,0  41,8±9,7  66,8±9,8 
HBO (+)  19,2±7  58,5±12,1  71,2±9,4  18,7±4,7  45,7±11  51,8±13,3  25,8±10,9  53±13,3  68,1±6,9 
Osteocalcin ( mean±SD 
ng/ml) 
HBO (-)  55,1±11  37,5±4,7  42,1±7,0  39,5±6,6  38,4±4,2  35,1±4,5  38,0±5,0  38,6±6,4  39,1±9,3 
HBO (+)  44,7±5,7  49,5±6,5  41,3±5,4  40,3±6,8  45,2±7,9  40,8±6,3  39,0±6,3  40,2±8,1  39,4±5,2 
 
Electron microscopy observations 
In  the  ultrastructural  evaluation  of  the  perios-
teum in one and two week specimens in the control 
groups  without  HBOT,  there  were  numerous  chon-
droblasts  and  rarely  osteoblasts  that  contain 
well-developed  intra-cytoplasmic  organelles  (Figure 
5). Among these, the granular endoplasmic reticulum 
was prominent and golgi apparatus were clearly visi-
ble. The chondroblasts were positioned closely, leav-
ing  limited  intercellular  space  which  also  contains 
dispersed collagen fibrils. In four weeks, osteoblasts 
with reactive appearance were abundant and the col-
lagen fibrils had became more organized. In B-TCP 
groups,  the  general  ultrastructural  appearance  re-
sembles  to  that  of  the  controls.  In  addition,  it  was 
noted that in some areas the residual graft material 
had  came  in  contact  with  the  periosteum  and  the 
periosteal  cells  had  cytoplasmic  process  protruded 
through  the  bone  graft.  On  the  contrary,  the  ultra-
structural  investigation  of  CPCBB  groups  revealed 
evidences of severe degeneration both in the intra and 
extra cellular regions. At one week, normal appear-
ances  of  the  chondroblasts  were  observed  to  be  al-
tered and these cells also contained degenerated in-
tracellular components. In two and four week speci-
mens, the osteoblast mitochondrion had also lost their 
usual shape and there were empty intracellular spaces 
that contain no visible organelles, indicating a vacuo-
lar degeneration process. Moreover, the endoplasmic 
reticulum  membranes  were  swollen  and  the  nuclei 
were pyknotic. The collagen fibrils were scarce and Int. J. Med. Sci. 2011, 8 
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they  presented  a  dispersed  and  disorganized  struc-
ture. 
The  ultrastructural  findings  in  the  Control  + 
HBOT  and  B-TCP  +  HBOT  (Figure  6)  groups  were 
similar  to  their  non-HBO  counterparts  with  the  ex-
ceptions of dominant cell types and collagen structure 
at the early stages of healing. Our observations at one 
week specimens revealed that the chondroblasts had 
become  scarce  and  they  were  mainly  replaced  by 
highly active osteoblasts that contain well-developed 
intracytoplasmic  organelles.  Additionally,  the  colla-
gen fibrils appeared to be more organized in bundles. 
On the other hand, HBOT did not seem to have an 
effect over the periosteal cell structure of the CPCBB 
group (Figure 7 a and b) as the cellular degeneration 
findings  were  still  clearly  visible  at  all  time  points 
(Figure 8). 
 
Figure 5 The ultrastructural appearance of two periosteal osteoblast cells with well developed intracytoplasmic organelles 
in the control group without HBOT at one week time point ( TEM ×6000) (N; Nucleus, Ger; Granular endoplasmic 
reticulum, Mi; Mitochondrion; Cf; Collagen Fibrils). 
 
Figure 6 Residual β-TCP bone graft material is seen between two osteoblast cells of the periosteum, note the cytoplasmic 
processes (arrows) extending from the cell membrane to the bone graft substitute. This electron micrograph was taken 
from the β-TCP + HBOT group which were sacrificed at one week time point (TEM×7500) (N; Nucleus, R; Ribosome, Ger; 
Granular Endoplasmic Reticulum). Int. J. Med. Sci. 2011, 8 
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Figure  7  (a)  The ultrastructural view of the periosteum in β-TCP group following four week of HBOT. Note well 
developed membranes of the highly active intracytoplasmic organelles (TEM×6000) (N;Nucleus, Mi; Mitochondrion, Li; 
Lisosome, Ger; Granular endoplasmic reticulum, Cf; Collagen fibrils) (b) Four week of HBOT could not prevent the 
damages in the periosteum of the CPCBB group. This electron micrograph shows the extent of degeneration in two 
periosteal cells. The swollen membranes, the pyknotic nuclei and the dispersed collagen fibrils can be seen as the evidences 
of deterioration in the cellular structure of this group (TEM×7500) (N; Nucleus, Mi; Mitochondrion,  Ger;  Granular 
endoplasmic reticulum, Pli; Phagocytic lisosome, Cf; Collagen Fibrils).  
 
 
Figure 8 Ultrastructural findings of extensive degeneration in the periosteum of CPCBB + HBOT group at one week time 
point. It is clear that the the integrity of the cell membrane could not be maintained and there was also evidence of vacuolar 
degeneration (stars) in the intracytoplasmic compartment (TEM×7500) (Gm; graft material, Cf; Collagen fibrils). Int. J. Med. Sci. 2011, 8 
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Serum osteocalcin levels 
The serum osteocalcin levels were significantly 
higher in the Control + HBO group (49,5±6,5 ng/ml) 
when compared to the control animals which did not 
receive HBOT (37,5±4,7 ng/ml) (p<0.05) at two weeks 
samples. No significant differences indicating a bio-
chemical effect of HBOT could be found among other 
groups with respect to the serum osteocalcin levels. 
Discussion 
Bone  tissue  is  a  highly  evolved  and  complex 
structure which has the ability to heal itself effective-
ly. Therefore, an artificially produced bone substitute 
should at least present some of its biological proper-
ties (20). Characteristics of cell migration, angiogene-
sis (21) and particle size (22) are among the crucial 
factors  that  determine  the  interaction  of  the  bone 
grafts  with  the  recipient  tissue.  During  the  healing 
process, precursor cells and different signaling mol-
ecules mainly originate from the bone marrow, peri-
osteum and the defect margins (23). New bone for-
mation  and  angiogenesis  are  closely  related  to  the 
extent  of  tissue  oxygenation  (24).  HBOT  has  been 
shown to improve the healing of hard and soft tissue 
wounds  under  hypoxic  and  normal  conditions  by 
stimulating angiogenesis and oxygenation (25). Based 
on this knowledge, our experiments were carried out 
on a previously studied animal model (26) to which 
we applied commercially available bone graft materi-
als of similar particle size. Due to the complexity of 
the  bone  healing  process,  we  included  light  micro-
scopic, ultrastuctural and biochemical analysis in our 
study. To easily detect possible histological and bio-
chemical changes, we selected our harvest time points 
according to previous reports indicating higher cel-
lular activity at these days (27). Similarly, our HBOT 
protocol was derived from clinical studies in which 
this procedure had been reported to demonstrate high 
therapeutic efficiency without any side effects (28). 
The  effects  of  various  HBOT  protocols  on  the 
healing of normally perfused bone injuries have been 
extensively investigated using different experimental 
settings. In the earlier studies, the adjunctive HBOT 
was  found  to  improve  the  calcium  binding  and  re-
sistance of femur fractures (29) and also the torsional 
strength  of  distracted  rabbit  tibiae(30)Nilsson  et  al. 
(31) compared the influences of heparin, dextrane and 
HBOT in preventing soft and hard tissue damages in 
experimentally  created  vertical  ramus  osteotomies. 
They reported that the ten days 2,8 ATA once daily 80 
minutes of HBOT, had suppressed the inflammation 
and also increased the fusion rate of fractures when 
compared to the groups without HBOT. Same authors 
(32) also evaluated the hard tissue deposition around 
an  implanted  bone  harvest  chamber  and  they  ob-
served  a  significant  increase  in  the  new  bone  for-
mation following three weeks 2,8 ATA once daily 120 
minutes of HBOT. Penttinen et al.(33)investigated the 
effects of 2,5 ATA twice daily 120 minutes of HBOT 
on experimentally created rat femur fractures. They 
reported that the fracture mineralization was higher 
in HBOT given rats at two weeks, when compared to 
the  non-HBOT  animals.  Histopathologically,  they 
observed hypertrophic chondrocytes and significant 
new bone formation in HBOT groups at the same time 
point.  More  recently,  Jan  et  al.(34)investigated  the 
effects of 2,4 ATA once daily 90 minutes of HBOT for 
20 days on the healing of rabbit critical size calvarial 
defect model in which the animals were sacrificed at 
six and 12 weeks time points. They observed that the 
HBOT group produced a tissue regenerate with many 
blood vessels and cellular marrow spaces. Also, their 
histomorphometric analysis demonstrated more bone 
formation in the HBOT group when compared to the 
non-HBOT animals. Although these previous reports 
were not directly comparable with our results due to 
the inconsistency of animal models and HBOT pro-
cedures, our findings showed a similar pattern in the 
healing of control defects in rats given HBOT. In light 
microscopy, we observed an increase in the new bone 
formation as well as less fibrous tissue and cartilage 
matrix in HBOT given control animals at one and two 
weeks specimens. These subjective findings were also 
confirmed to some extent with bone histomorphome-
try. In the ultrastructural analysis, the periosteum of 
HBOT groups was observed to contain active osteo-
blasts and well-organized collagen fibrils when com-
pared to the chondroblast dominated and dispersed 
collagenous structure in the non-HBOT groups. Fur-
thermore, new bone formation had become detectable 
biochemically in the HBOT given rats, as the serum 
osteocalcin levels were significantly higher than the 
non-HBOT  group  at  two  weeks  serum  samples. 
Therefore, we think that the HBOT contributed posi-
tively to the healing process of empty defects in rat 
tibiae.  
Tricalcium  phosphate  based  bone  substitutes 
and  particulated  bovine  bone  grafts  were  histologi-
cally compared in a number of experimental studies 
which  produced  conflicting  results  (35,36).  In  our 
study, we observed that the defects filled with CPCBB 
showed a more regular new bone apposition-material 
resorption pattern when compared to the β-TCP. Al-
so,  at  four  weeks,  the  healing  of  these  defects  was 
similar to that of the control group. On the other hand, 
our  ultrastructural  investigation  revealed  that  the 
CPCBB caused severe degeneration in both extra and Int. J. Med. Sci. 2011, 8 
 
http://www.medsci.org 
123 
intracellular components of the periosteum with no 
apparent clinical signs of inflammation or infection. In 
contrast, the β-TCP particles had acceptable integra-
tion with periosteal cells. These interesting and pre-
viously unreported findings suggest the necessity of 
multidisciplinary  study  designs  which  take  into  ac-
count different characteristics of the tissues involved 
in host tissue – bone graft interactions. 
The  use  of  adjunctive  HBOT  to  improve  bone 
healing in autogenous bone transplants has been in-
vestigated  in  the  histologic  observation  of  the  iliac 
grafts  placed  in  mandibular  defects  of  animals  re-
vealed that 2,4 ATA 60 minutes twice daily (20 ses-
sions before 10 sessions after the surgery) HBOT en-
couraged new vessel formation at one week and new 
bone deposition at two week time points (37) Addi-
tionally, the spinal fusion rate and torsional strength 
have  been  found  to  be  higher  in  a  rabbit  poste-
ro-lateral intertranverse fusion model with adjunctive 
HBOT(38).  This  treatment  modality  has  also  been 
shown  to  increase  bone  formation,  serum  alkaline 
phosphatase  activity  and  calcium  levels  when  bone 
morphogenetic proteins were implanted to normally 
perfused (39) or ischemic regions (40) in a rat model. 
Jan  et  al.(41)  reported  that  the  unfilled  critical-size 
calvarial defects in animals exposed to HBOT had less 
fibrous  tissue,  more  new  bone  and  marrow  for-
mations  than  unfilled  non-HBOT  defects.  However, 
they  did  not  find  any  statistical  difference  in  bone 
formation  parameters  between  defects  grafted  with 
autogenous  bone  in  non-HBOT  and  HBOT  groups. 
When similar defects were filled with demineralized 
bone  matrix  (DBM)  or  biphasic  calcium  phosphate 
(BCP) bone substitutes and exposed to 20 sessions 2,4 
ATA once daily 90 minutes of HBOT (42), a significant 
increase in the new bone formation in DBM-grafted 
sites and less fibrous tissue in BCP implanted defects 
were observed. Our histomorphometric findings also 
revealed less fibrous tissue in CPCBB + HBOT groups. 
In  addition,  we  found  that  the  cartilaginous  matrix 
formation  significantly  decreased  in  all  groups.  Be-
tween  two  grafting  materials,  the  HBOT  promoted 
new bone formation  only in β-TCP filled defects at 
one and two week time points. However, the overall 
healing in these defects was still inferior to controls 
and CPCBB groups with or without HBOT.  
Different  healing  patterns  observed  with  two 
bone substitutes in response to the same HBOT pro-
cedure could be partially explained by the basic tissue 
effects of HBOT and local characteristics of the bone 
grafts.  Collagen  synthesis  from  fibroblasts  and  the 
formation of osteoid substance by osteoblasts are both 
oxygen-dependent  processes  (43).  Vascular  disrup-
tion and hypoxia are natural consequences of the bone 
defects which, if extended, could change the overall 
healing pattern (44). Hypoxia promotes chondrocytic 
differentiation  and  cartilage  matrix  synthesis  (45). 
Therefore, the collagen tissue organization and early 
osteoblast  detection  in  periosteum  as  well  as  new 
bone, less fibrous and less cartilage tissue formations 
in the defects of animals exposed to HBOT may be 
related  to  the  increased  partial  pressure  and  trans-
portation of oxygen in HBOT groups. On the other 
hand, larger gaps between the β-TCP particles which 
were  observed  to  be  filled  with  connective  tissue 
could have provided more space for the new bone in 
growth  related  to  HBOT,  whereas  the  intact  but 
steadily resorptive structure and/or the degeneration 
in periosteum of CPCBB specimens could have lim-
ited the effects of HBOT on these groups. From this 
point of view, these findings could also suggest that 
the  successful  interaction  of  a  bone  graft  substitute 
with the host tissue under normobaric conditions may 
not be indicative of the similar process under hyper-
baric environment. 
Conclusion 
HBOT has led to an increase in new bone for-
mation and improved the cellular structure as well as 
the collagen fibril organization in the periosteum of 
the unfilled and β-TCP filled defects. This process was 
also  biochemically  detectable  in  the  control  group. 
Generally,  HBOT  resulted  in  a  reduction  in  fibrous 
tissue and cartilage matrix formation but it was not 
prominently effective in the healing of CPCBB filled 
defects. 
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